ADVFN ADVFN

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Caratteristiche principali

Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Taysha Gene Therapies Inc

Taysha Gene Therapies Inc (TSHA)

5,365
-0,065
( -1,20% )
Aggiornato: 19:21:36

Taysha Gene Therapies Inc (TSHA) Operazioni degli insider

-
Filtra per:
Data Nome del titolare Azioni transazionate Intervallo di valore ($) Tipo di transazione Intervallo di prezzo ($) Azioni a fine dichiarazione % di variazione
2026-04-10Dr. Sukumar NagendranPresident, Head of Research & Development and Director-180,98k807,17kAutomatic Disposition4,4634,23k-84,10%
2026-04-10Dr. Sukumar NagendranPresident, Head of Research & Development and Director-19,02k52,31kDerivative Exercise and Sale1,71 - 4,4634,23k-
2026-02-04Mr. Kamran AlamCFO & Corporate Secretary-1,66k7,48kVendita4,521,44M-0,11%
2026-01-23Mr. Kamran AlamCFO & Corporate Secretary-102,82k485,04kVendita4,61 - 4,751,44M-6,65%
2026-01-23Mr. Sean P. NolanCEO & Chairman-178,10k840,20kVendita4,61 - 4,75638,54k-21,81%
2026-01-23Dr. Sukumar NagendranPresident, Head of Research & Development and Director-116,05k547,47kVendita4,61 - 4,75215,21k-35,03%
2026-01-12Dr. Sukumar NagendranPresident, Head of Research & Development and Director-200,00k712,56kDerivative Exercise and Sale0,70 - 4,71331,26k-
2025-11-28Dr. Sukumar NagendranPresident, Head of Research & Development and Director-370,17k1,13MDerivative Exercise and Sale0,70 - 4,7534,23k-
2025-09-10Dr. Sukumar NagendranPresident, Head of Research & Development and Director-41,15k104,15kDerivative Exercise and Sale0,70 - 3,2334,23k-
2025-09-10Dr. Sukumar NagendranPresident, Head of Research & Development and Director-158,85k513,09kAutomatic Disposition3,2334,23k-82,27%
2025-08-21Mr. Kamran AlamCFO & Corporate Secretary-54,49k155,30kVendita2,851,19M-4,39%
2025-08-21Dr. Sukumar NagendranPresident, Head of Research & Development and Director-57,05k162,60kVendita2,85193,08k-22,81%